Eventide Asset Management - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$164,521,000
-15.1%
1,129,100
-30.9%
3.52%
+15.8%
Q1 2022$193,862,000
-14.0%
1,635,0000.0%3.04%
+5.5%
Q4 2021$225,319,000
+22.4%
1,635,000
+23.4%
2.88%
+18.6%
Q3 2021$184,056,000
-4.8%
1,325,000
-33.4%
2.43%
-6.5%
Q2 2021$193,267,000
+40.3%
1,990,797
-1.2%
2.60%
+27.2%
Q1 2021$137,725,000
-9.9%
2,015,000
+13.0%
2.04%
-12.9%
Q4 2020$152,886,000
+31.8%
1,783,7610.0%2.34%
+3.3%
Q3 2020$115,962,000
-11.1%
1,783,7610.0%2.27%
-19.9%
Q2 2020$130,411,000
+114.8%
1,783,7610.0%2.84%
+44.2%
Q1 2020$60,701,000
-31.8%
1,783,761
+9.2%
1.97%
-21.6%
Q4 2019$88,955,000
+30.5%
1,634,0000.0%2.51%
+11.3%
Q3 2019$68,170,000
+89.2%
1,634,000
+98.5%
2.25%
+105.5%
Q2 2019$36,039,000
+42.0%
823,000
+66.9%
1.10%
+25.5%
Q1 2019$25,375,000
+39.2%
493,0000.0%0.87%
+8.2%
Q4 2018$18,231,000
+65.1%
493,000
+67.7%
0.81%
+99.3%
Q3 2018$11,040,000
+10.0%
294,000
+15.7%
0.40%
-2.9%
Q2 2018$10,038,000
+12.6%
254,000
-26.6%
0.42%0.0%
Q1 2018$8,913,000
+36.5%
346,000
+43.0%
0.42%
+22.6%
Q4 2017$6,529,000
+228.1%
242,000
+354.5%
0.34%
+200.9%
Q3 2017$1,990,000
+49.5%
53,2400.0%0.11%
+36.1%
Q2 2017$1,331,00053,2400.08%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders